Cite

HARVARD Citation

    Haugen, M. et al. (n.d.). 23PDesign of a protein signature predicting response to neo-adjuvant treatment with chemotherapy combined with bevacizumab in breast cancer patients. Annals of oncology. p. . [Online]. 
  
Back to record